Target intelligence / Profile preview

Rho Antigen (D)

Target
D
Molecular classification
Multi-pass transmembrane protein, RH Blood Group System Antigen
01

Overview

The Rho antigen, or D antigen, is a highly immunogenic surface protein on red blood cells, encoded by the *RHD* gene. Its presence defines Rh-positive blood type, while its absence defines Rh-negative. The D antigen plays a critical role in transfusion medicine and is the primary target in Hemolytic Disease of the Fetus and Newborn (HDFN) when an Rh-negative mother carries an Rh-positive fetus. Rho(D) immune globulin (anti-D) is administered to Rh-negative pregnant women to prevent alloimmunization.

Other names
Rh(D) antigenRh factor
02

Mechanism of action

Rho(D) immune globulin prevents alloimmunization by binding to Rh-positive fetal red blood cells in the maternal circulation and promoting their clearance, thus preventing the mother's immune system from recognizing them as foreign and producing anti-D antibodies. It may also modulate immune response in autoimmune conditions.

03

Biological functions

Determines Rh positive/negative blood typeRed blood cell structural component
04

Disease associations

Hemolytic Disease of the Newborn (HDFN/HDN)Hemolytic Transfusion ReactionsAutoimmune hemolytic anemia (indirectly)
05

Safety considerations

Risk of allergic reactions to Rho(D) immune globulinTransmission of infectious agents (rare with modern purification methods)Incorrect Rh typing leading to inappropriate administration of Rho(D) immune globulin
06

Interacting drugs

Rho(D) immune globulin (anti-D)
07

Biomarkers

Presence or absence of D antigen on red blood cells (RhD typing)

Beyond the preview

Go deeper on Rho Antigen (D).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rho Antigen (D).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call